MORRISON JODIE POPE (Interim CEO) received a stock award from KERYX BIOPHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/14/2018ACC: 0001114220-18-000052
DirectorOfficer· Interim CEO
Since Jun 2018
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
1000.0%
5/10/2018
10K→110K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/10/2018 | A · Award | +100K | — | — | 1000.0% | 10K | 110K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported